Annual accounts
Total Exemption Full accounts
31/03/2026Filing deadline
- Next accounts made up to
- 31/03/2025
- Last accounts made up to
- 31/03/2024
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Total exemption full accounts made up to 2025-03-31
Confirmation statement made on 2025-12-04 with updates
Director's details changed for Dr. Natasha Hilton on 2025-12-04
Total exemption full accounts made up to 2024-03-31
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Total Exemption Full accounts
31/03/2026Filing deadline
Confirms the registry record is up to date
The latest figures GENESYS BIOTECH LTD filed. Okredo holds filed accounts data for 2021–2024; the year-by-year record is on the financials page.
Net Assets
2023: £31.24M
Total Assets
2023: £31.92M
Cash in Bank
2023: £29.70M
Total Liabilities
2023: £309.68K
Employees
2023: 11
Of the 4 measures with an earlier filing to compare against, 4 rose. Cash in bank moved furthest, up 2.78% on 2023. See the full financial analysis for GENESYS BIOTECH LTD.
The full financial record
Four ways through GENESYS BIOTECH LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2024.
| Year | Employees | Change |
|---|---|---|
| 2024 | 11 | 0 |
| 2023 | 11 | 0 |
| 2022 | 11 | 0 |
| 2021 | 11 | – |
Reported employee count was unchanged at 11 between 2021 and 2024. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Nominee Secretary | 27/11/2002–06/12/2002 | 68517 | |
| Nominee Director | 27/11/2002–06/12/2002 | 67500 | |
| Director | 06/12/2002–05/11/2024 | 9 | |
| Director | 30/03/2023–Present | 8 | |
| Director | 30/03/2023–Present | 4 | |
| Secretary | 06/12/2002–05/11/2024 | 1 | |
| Director | 30/03/2023–30/04/2026 | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–30/03/2023 | 9 | |
| 06/04/2016–Present | 9 | |
| 27/10/2020–30/10/2024 | 8 | |
| 27/10/2020–Present | 8 | |
| 27/10/2020–30/10/2024 | 4 | |
| 27/10/2020–Present | 4 | |
| 30/10/2024–Present | 0 |
Every document on the Companies House record, newest first.
Total exemption full accounts made up to 2025-03-31
Confirmation statement made on 2025-12-04 with updates
Director's details changed for Dr. Natasha Hilton on 2025-12-04
Total exemption full accounts made up to 2024-03-31
Director's details changed for Mrs Sarah Louise Dugdale on 2025-01-30
Confirmation statement made on 2024-12-04 with updates
Cessation of Nicholas Richard Morant as a person with significant control on 2024-10-30
Notification of Genesys Biotech Eot Limited as a person with significant control on 2024-10-30
Cessation of Sarah Louise Dugdale as a person with significant control on 2024-10-30
Termination of appointment of Duncan Roy Clark as a director on 2024-11-05
Termination of appointment of Angela Carolyn Clark as a secretary on 2024-11-05
Registered office address changed from , Backhouse Yong Partnership Chartered Acountants the Old Forge, Wendens Ambo, Saffron Walden, Essex, CB11 4JL to 2nd Floor Butler House 177-178 Tottenham Court Road London W1T 7AF on 2024-10-14
Showing 12 of 23 filings
See when the next accounts and confirmation statement are due
40 UK companies are similar to GENESYS BIOTECH LTD, sharing the same company status (Active), the same industry sector and activity group (Other research and experimental development on natural sciences and engineering) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
Meacher-Jones, 6 St John's Court, Vicars Lane, Chester, Cheshire CH1 1QE
167-169 Great Portland Street, London W1W 5PF
3 St George's Mews, Westminster Bridge Road, London SE1 7JB
Camburgh House, 27 New Dover Road, Canterbury, Kent CT1 3DN
1 Friar Street, Reading RG1 1DA
A short description of the company, written from its Companies House record.
GENESYS BIOTECH LTD is a private limited company registered in the United Kingdom, based in 2nd Floor Butler House, 177-178 Tottenham Court Road, London W1T 7AF. Companies House classifies its business as Other research and experimental development on natural sciences and engineering. It has been on the register for 23 years 9 months.
The register currently records it as active. Its 2024 accounts report net assets of £31.24M and 11 employees. Its accounts are past the filing deadline shown on the registry record.
Answered from this company's own registry record and filed figures.
Companies House records GENESYS BIOTECH LTD under one registered business activity: Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007).
GENESYS BIOTECH LTD is recorded as active on the Companies House register, and has been on it since 27/11/2002.
The most recent accounts Okredo holds cover 2024 and report net assets of £31.24M, total assets of £32.39M, cash in bank of £30.52M and total liabilities of £785.99K.
The most recent document on the record is dated 31/03/2026: Total exemption full accounts made up to 2025-03-31, 5 months ago.
On the current registry record, accounts are due by 31/03/2026, which has passed.
Companies House lists 7 officers (2 currently in post) and 7 people with significant control (4 current).